252 related articles for article (PubMed ID: 19223151)
1. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
[TBL] [Abstract][Full Text] [Related]
2. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
3. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
4. The effect of attributional processes concerning medication taking on return of fear.
Powers MB; Smits JA; Whitley D; Bystritsky A; Telch MJ
J Consult Clin Psychol; 2008 Jun; 76(3):478-90. PubMed ID: 18540741
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
7. Augmenting in vivo exposure with fear antagonistic actions: a preliminary test.
Wolitzky KB; Telch MJ
Behav Ther; 2009 Mar; 40(1):57-71. PubMed ID: 19187817
[TBL] [Abstract][Full Text] [Related]
8. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
Smits JA; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG; Powers MB
Biol Psychiatry; 2014 Jun; 75(11):840-6. PubMed ID: 24237691
[TBL] [Abstract][Full Text] [Related]
9. Does the judicious use of safety behaviors improve the efficacy and acceptability of exposure therapy for claustrophobic fear?
Deacon BJ; Sy JT; Lickel JJ; Nelson EA
J Behav Ther Exp Psychiatry; 2010 Mar; 41(1):71-80. PubMed ID: 19892318
[TBL] [Abstract][Full Text] [Related]
10. Fear activation and distraction during the emotional processing of claustrophobic fear.
Telch MJ; Valentiner DP; Ilai D; Young PR; Powers MB; Smits JA
J Behav Ther Exp Psychiatry; 2004 Sep; 35(3):219-32. PubMed ID: 15262218
[TBL] [Abstract][Full Text] [Related]
11. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
Berry AC; Rosenfield D; Smits JA
Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone renders one-session exposure therapy less effective: a controlled pilot study.
Kozak AT; Spates CR; McChargue DE; Bailey KC; Schneider KL; Liepman MR
J Anxiety Disord; 2007; 21(1):142-52. PubMed ID: 16647240
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
14. Cognitive behavioral therapy for public-speaking anxiety using virtual reality for exposure.
Anderson PL; Zimand E; Hodges LF; Rothbaum BO
Depress Anxiety; 2005; 22(3):156-8. PubMed ID: 16231290
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of a broad-spectrum cognitive-behavioral group therapy for anxiety.
Norton PJ; Hope DA
J Behav Ther Exp Psychiatry; 2005 Jun; 36(2):79-97. PubMed ID: 15814078
[TBL] [Abstract][Full Text] [Related]
16. Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.
Tillfors M; Carlbring P; Furmark T; Lewenhaupt S; Spak M; Eriksson A; Westling BE; Andersson G
Depress Anxiety; 2008; 25(8):708-17. PubMed ID: 18729147
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and cognitive group treatment for fear of flying: a randomized controlled trial.
Van Gerwen LJ; Spinhoven P; Van Dyck R
J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):358-71. PubMed ID: 16828460
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.
Prasko J; Dockery C; Horácek J; Houbová P; Kosová J; Klaschka J; Pasková B; Praskova H; Seifertová D; Záleský R; Höschl C
Neuro Endocrinol Lett; 2006 Aug; 27(4):473-81. PubMed ID: 16891998
[TBL] [Abstract][Full Text] [Related]
19. The role of imagery in the maintenance and treatment of snake fear.
Hunt M; Bylsma L; Brock J; Fenton M; Goldberg A; Miller R; Tran T; Urgelles J
J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):283-98. PubMed ID: 16473325
[TBL] [Abstract][Full Text] [Related]
20. Specific phobias.
Hamm AO
Psychiatr Clin North Am; 2009 Sep; 32(3):577-91. PubMed ID: 19716991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]